Standout Papers
- Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation (1993)
- ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia (2004)
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma (1991)
- Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial (2018)
- Chronic lymphocytic leukaemia (2017)
- Bone marrow niches in haematological malignancies (2020)
Immediate Impact
45 by Nobel laureates 53 from Science/Nature 119 standout
Citing Papers
Past, present, and future of CRISPR genome editing technologies
2024 Standout
Diffuse Large B-Cell Lymphoma
2021 Standout
Works of John G. Gribben being referenced
Interim Results from an Ongoing Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
2018
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| John G. Gribben | 9015 | 8634 | 10736 | 471 | 23.5k | |
| Jan A. Burger | 12612 | 8272 | 7637 | 427 | 20.5k | |
| Tadeusz Robak | 9615 | 7531 | 5138 | 688 | 18.7k | |
| John C. Byrd | 14705 | 10360 | 7768 | 696 | 27.4k | |
| Stephan Stilgenbauer | 15835 | 12696 | 7676 | 511 | 22.9k | |
| Brunangelo Falini | 7426 | 15273 | 7782 | 382 | 32.4k | |
| Gianluca Gaïdano | 7588 | 10840 | 4488 | 610 | 20.0k | |
| Stefano Pileri | 6937 | 19624 | 7044 | 531 | 29.8k | |
| Stephen M. Ansell | 5515 | 13439 | 8639 | 732 | 25.9k | |
| Neil E. Kay | 11084 | 8346 | 6796 | 491 | 16.9k | |
| Martin J.S. Dyer | 5986 | 6400 | 4822 | 298 | 16.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...